![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.00 | 13.00 | 35.00 | 24.00 | 24.00 | 24.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.59 | 35.84M |
RNS Number:5762V Cambridge Antibody Tech Group PLC 11 December 2000 The issuer has made the following amendment to the Director Shareholding announcement released 1 December 2000 at 13:24 under RNS No 0981V. The total holding of Peter Garland in Box 15 should read 50,006 and not 49,500 as previously shown. All other details remain unchanged. The full corrected version is shown below. Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Kevin Johnson 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Exercise and sale of 59,242 options granted under Company Share Option Scheme. 7 Number of shares/amount of stock acquired: 59,242 8 Percentage of issued class: 0.17% 9 Number of shares/amount of stock disposed: 59,242 10 Percentage of issued class: 0.17% 11 Class of security: 10p ordinary shares 12 Price per share: #41.00 13 Date of transaction: 28 September 2000 14 Date company informed: 28 September 2000 15 Total holding following this notification: 63,627 (with spouse) 16 Total percentage holding of issued class following this notification: 0.18% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: David Glover 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Exercise of 45,000 options and sale of 43,000 options granted under Company Share Option Scheme. 7 Number of shares/amount of stock acquired: 45,000 8 Percentage of issued class: 0.13% 9 Number of shares/amount of stock disposed: 43,000 10 Percentage of issued class: 0.12% 11 Class of security: 10p ordinary shares 12 Price per share: #41.00 13 Date of transaction: 28 September 2000 14 Date company informed: 28 September 2000 15 Total holding following this notification: 9,327 16 Total percentage holding of issued class following this notification: 0.03% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Peter Garland 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Sale of shares 7 Number of shares/amount of stock acquired: Nil 8 Percentage of issued class: 9 Number of shares/amount of stock disposed: 32,500 10 Percentage of issued class: 0.09% 11 Class of security: 10p ordinary shares 12 Price per share: #41.00 13 Date of transaction: 28 September 2000 14 Date company informed: 28 September 2000 15 Total holding following this notification: 50,006 (with spouse) 16 Total percentage holding of issued class following this notification: 0.14% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: David Chiswell 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: Spouse 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): Linda Chiswell 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): Spouse 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Sale of shares 7 Number of shares/amount of stock acquired: Nil 8 Percentage of issued class: 9 Number of shares/amount of stock disposed: 150,000 10 Percentage of issued class: 0.43% 11 Class of security: 10p ordinary shares 12 Price per share: #41.00 13 Date of transaction: 28 September 2000 14 Date company informed: 28 September 2000 15 Total holding following this notification: 476,127 16 Total percentage holding of issued class following this notification: 1.36% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Sir Aaron Klug 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 and spouse 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): Sir Aaron Klug (15,649)and Lady Liebe Klug (12,408) 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): As in 2 and Spouse 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Sale of shares 7 Number of shares/amount of stock acquired: Nil 8 Percentage of issued class: 9 Number of shares/amount of stock disposed: 10,000 10 Percentage of issued class: 0.03% 11 Class of security: Ordinary 10p shares 12 Price per share: #41.00 13 Date of transaction: 28 September 2000 14 Date company informed: 28 September 2000 15 Total holding following this notification: 28,057 16 Total percentage holding of issued class following this notification: 0.08% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Additional Information: Correction of announcement. This is a correction of the announcement originally made on September 28, 2000 and amended on December 1 in respect of the dealings of Peter Garland only. BOX 15 CHANGED TO 50,006 ( PREVIOUSLY 49,500) REST OF ANNOUNCEMENT UNCHANGED
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions